Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 GBX | +9.62% | +0.80% | -17.00% |
May. 16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
May. 16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
Sales 2022 | 7.78M 9.93M | Sales 2023 | 5.03M 6.41M | Capitalization | 13.37M 17.06M |
---|---|---|---|---|---|
Net income 2022 | 1M 1.28M | Net income 2023 | -2M -2.55M | EV / Sales 2022 | 2.35 x |
Net Debt 2022 | 7.92M 10.11M | Net Debt 2023 | 11.45M 14.61M | EV / Sales 2023 | 4.94 x |
P/E ratio 2022 |
8.14
x | P/E ratio 2023 |
-5.46
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.53% |
1 day | +9.62% | ||
1 week | +0.80% | ||
Current month | +6.52% | ||
1 month | +4.44% | ||
3 months | -11.74% | ||
6 months | -37.59% | ||
Current year | -17.00% |
Managers | Title | Age | Since |
---|---|---|---|
Mariola Söhngen
CEO | Chief Executive Officer | 63 | 20-09-14 |
Abdelghani Omari
DFI | Director of Finance/CFO | 48 | 22-08-31 |
Chairman | 71 | 93-12-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 93-12-09 | |
Roger McDowell
BRD | Director/Board Member | 69 | 14-06-30 |
Ursula Ney
BRD | Director/Board Member | 72 | 17-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 3.76 | +9.62% | 296 489 |
24-05-24 | 3.43 | -4.72% | 50,346 |
24-05-23 | 3.6 | 0.00% | 5,051 |
24-05-22 | 3.6 | -3.49% | 463,833 |
24-05-21 | 3.73 | +6.57% | 269,232 |
Delayed Quote London S.E., May 28, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-17.00% | 12.93M | |
-7.54% | 181B | |
-0.30% | 108B | |
-7.01% | 66.12B | |
+2.96% | 50.65B | |
+5.20% | 43.11B | |
+3.49% | 40.74B | |
+19.48% | 31.6B | |
+16.38% | 25.56B | |
-6.93% | 24.16B |
- Stock Market
- Equities
- PRM Stock